Skip to main content
. 2018 May 8;38(3):BSR20180330. doi: 10.1042/BSR20180330

Table 2. Univariate and multivariate logistic regression analysis for poor outcome.

Parameter Univariate analysis Multivariate analysis1
OR (95% CI) P OR (95% CI) P
Age (increase per unit) 1.15 (1.06–1.27) <0.001 1.10 (1.04–1.18) 0.003
Male sex 1.28 (1.03–1.58) 0.26
BMI (increase per unit) 1.18 (1.05–1.30) 0.002 1.12 (1.04–1.25) 0.02
Infarct volume (increase per unit) 1.20 (1.08–1.33) 0.001 1.16 (1.04–1.27) 0.01
NIHSS score (increase per unit) 1.45 (1.21–1.66) <0.001 1.37 (1.18–1.53) 0.002
Time from onset to blood collection (increase per unit) 0.97(0.90–1.05) 0.13
Stroke syndrome
TACS 1.66 (0.65–3.22) 0.22
PACS 1.15 (0.81–1.83) 0.75
LACS 0.81 (0.47–1.66) 0.51
POCS 0.59 (0.32–1.40) 0.39
Stroke etiology
Small-vessel occlusive 0.64 (0.38–1.33) 0.45
Large-vessel occlusive 0.94 (0.68–1.27) 0.33
Cardioembolic 1.15 (0.94–1.46) 0.09
Other 1.22 (0.98–1.77) 0.26
Pre-stroke treatment (Yes compared with No) 0.93 (0.88–0.99) 0.03 0.95 (0.87–1.05) 0.09
Acute-stroke treatment (Yes compared with No) 0.85 (0.79–0.92) 0.006 0.91 (0.85–0.95) 0.01
Moderate-heavy physical activity 1.87 (1.13–2.56) 0.02 1.64 (1.05–2.68) 0.06
Blood pressure (increase per unit) 0.96 (0.90–1.13 0.12
Vascular risk factors (Yes compared with No) 1.44 (1.02–2.01) 0.04 1.36 (0.88–2.15) 0.18
Hs-CRP (increase per unit) 1.14 (1.03–1.22) 0.008 1.11 (1.04–1.20) 0.01
FBG (increase per unit) 1.06 (1.02–1.14) 0.005 1.03 (1.01–1.07) 0.008
HDL (increase per unit) 0.66 (0.50–1.05) 0.10
Triglycerides (increase per unit) 1.18 (0.92–1.77) 0.15
HOMA-IR 3.43 (2.21–5.33) <0.001 2.45 (1.59–4.07) <0.001

Abbreviations: HDL, high-density lipoprotein; LACS, lacunar syndrome; PACS, partial anterior circulation syndrome; POCS, posterior circulation syndrome; TACS, total anterior circulation syndrome.

1

Includes the significant risk factors in univariate logistic regression analysis for multivariate logistic analysis (age, BMI, infarct volume, NIHSS score, pre-stroke and acute treatment, physical activity, vascular risk factors and serum levels of Hs-CRP and FBG).